ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
RaceOncology
|
110 |
37K |
46 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
37K
|
46
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
RaceOncology
|
110 |
37K |
76 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
37K
|
76
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
RaceOncology
|
110 |
37K |
118 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
37K
|
118
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
RaceOncology
|
110 |
37K |
154 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
37K
|
154
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
22K |
7.7M |
12 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
22K
|
7.7M
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
22K |
7.7M |
26 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
22K
|
7.7M
|
26
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
22K |
7.7M |
87 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
22K
|
7.7M
|
87
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Offer Results
|
|
RaceOncology
|
35 |
12K |
10 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
35
|
12K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Offer Results
|
|
RaceOncology
|
35 |
12K |
15 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
35
|
12K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
769K |
61 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
2.2K
|
769K
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Offer Results
|
|
RaceOncology
|
35 |
12K |
56 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
35
|
12K
|
56
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
769K |
50 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
2.2K
|
769K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Offer Results
|
|
RaceOncology
|
35 |
12K |
85 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
35
|
12K
|
85
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
4.0M |
94 |
05/06/24 |
05/06/24 |
General
|
11K
|
4.0M
|
94
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
111 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.0K
|
306K
|
111
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
RaceOncology
|
2.9K |
1.0M |
40 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
RaceOncology
|
35 |
10K |
24 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
35
|
10K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
RaceOncology
|
35 |
10K |
42 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
35
|
10K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
64 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
306K
|
64
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
905 |
269K |
74 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
905
|
269K
|
74
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
RaceOncology
|
10 |
4.7K |
94 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
10
|
4.7K
|
94
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
RaceOncology
|
126 |
31K |
21 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
126
|
31K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
1.0K
|
306K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
[WEBINAR REPLAY] What it takes to get a new drug to market in Australia
|
|
RaceOncology
|
37 |
9.3K |
17 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
37
|
9.3K
|
17
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
4.0M |
55 |
27/05/24 |
27/05/24 |
General
|
11K
|
4.0M
|
55
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
41 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
306K
|
41
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
46 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
306K
|
46
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
RaceOncology
|
126 |
31K |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
126
|
31K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
RaceOncology
|
126 |
31K |
6 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
126
|
31K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
RaceOncology
|
126 |
31K |
30 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
126
|
31K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
769K |
42 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
2.2K
|
769K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
769K |
15 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
2.2K
|
769K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
RaceOncology
|
126 |
31K |
45 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
126
|
31K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
7 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
1.0K
|
306K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
769K |
24 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
2.2K
|
769K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
769K |
20 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
2.2K
|
769K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
769K |
57 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
2.2K
|
769K
|
57
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
RaceOncology
|
234 |
65K |
97 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
234
|
65K
|
97
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
RaceOncology
|
234 |
65K |
57 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
234
|
65K
|
57
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
1.0K
|
306K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Michael Kelso etc
|
|
RaceOncology
|
12 |
3.8K |
47 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
12
|
3.8K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
RaceOncology
|
234 |
65K |
57 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
234
|
65K
|
57
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
14 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
1.0K
|
306K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
RaceOncology
|
234 |
65K |
57 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
65K
|
57
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
769K |
18 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
2.2K
|
769K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
RaceOncology
|
234 |
65K |
71 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
65K
|
71
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
RaceOncology
|
234 |
65K |
62 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
65K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
RaceOncology
|
234 |
65K |
54 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
65K
|
54
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
905 |
269K |
112 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
905
|
269K
|
112
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
1.0K |
306K |
14 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
1.0K
|
306K
|
14
|
|